BRIEF-Clarity Pharmaceuticals To Commence Phase III Trial Of 64 Cu-Sartate In NETS

Reuters
Dec 22, 2025
BRIEF-<a href="https://laohu8.com/S/CU6.AU">Clarity Pharmaceuticals</a> To Commence Phase III Trial Of 64 <a href="https://laohu8.com/S/CUNB">Cu</a>-Sartate In NETS

Dec 22 (Reuters) - Clarity Pharmaceuticals Ltd CU6.AX:

  • TO COMMENCE PHASE III TRIAL OF 64 CU-SARTATE IN NETS

Further company coverage: CU6.AX

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10